products focus on moisturizing and strengthening fragile skin.
In 2014, the FDA and FTC took action against Dermatend (Original and Ultra) for several critical safety reasons:
Using at-home removal creams can lead to permanent scarring and infection.
The product was marketed over-the-counter (OTC) for mole and skin tag removal without FDA approval.